‘Inverse vaccines’: the promise of a ‘holy grail’ treatment for autoimmune diseases
Some researchers say a new approach, which suppresses a particular part of the immune system rather than amplifying it, could be available in the next five years
Autoimmune diseases affect as many as 800 million people around the world – around one in 10 of us. From multiple sclerosis and lupus to type one diabetes and rheumatoid arthritis, these conditions all share a common trait: the body’s own immune system turns against itself.